Oncology Innovations: Applying the Latest Evidence in Extensive-Stage Small Cell Lung Cancer Care

Course Overview

Small-cell lung cancer (SCLC) is an aggressive malignancy with historically limited therapeutic progress. Recently, however, new therapeutic combinations and treatments are changing the treatment paradigm, improving survival, and bringing hope to the tens of thousands who receive a diagnosis of SCLC each year.

This on-demand video webcast will cover:

  • Efficacy and safety data from recently approved SCLC therapies and combinations, phase 3 data evaluating first-line maintenance with PD-L1 inhibition plus a novel alkylator
  • Long-term efficacy from practice-changing immunotherapy combinations
  • Practical guidance for recognizing and managing immune-related adverse events
  • Promising approaches including using B7-H3–directed antibody-drug conjugates and DLL3-targeted bispecific antibodies

As systemic therapy options expand, it is critical that providers remain current on evolving data to ensure optimal patient outcomes.

Stephen Liu
Stephen Liu, MD - Chair Faculty

Associate Professor of Medicine, Director, Thoracic Oncology Head, Developmental Therapeutics Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC


Jeffrey P. Ward
Jeffrey P. Ward, MD, PhD - Presenting Faculty, St. Louis

Assistant Professor of Medicine in the Division of Medical
Oncology at Washington University School of Medicine and Siteman Cancer Center in St.
Louis, Missouri


Sonam Puri
Sonam Puri, MD – Presenting Faculty, St. Petersburg

Associate Member, Department of Thoracic Oncology
Associate Professor, Department of Oncologic Sciences, University of South Florida
Clinical Research Medical Director, Department of Thoracic Oncology
Moffitt Cancer Center, Tampa, Florida


Mariam Alexander
Mariam Alexander, MD, PhD – Presenting Faculty - On-Demand Webinar

Assistant Professor, Medical Oncology
MUSC Health Hematology Oncology at Hollings Cancer Center, Charleston, South Carolina


Misty D. Shields
Misty D. Shields, MD, PhD – Presenting Faculty, Fort Wayne

Assistant Professor of Medicine, Indiana University School of Medicine
Adjunct Assistant Professor of Medical & Molecular Genetics
Associate Member, Experimental and Developmental Therapeutics
Department of Medicine, Division of Hematology/Oncology, Thoracic Oncology
Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianapolis, IN


Wade Iams
Wade Iams, MD, MSCI – Presenting Faculty, Chattanooga

Director, Lung Cancer Research Greco Hainsworth Centers for Research Tennessee Oncology, Nashville, Tennessee


Eric Singhi
Eric Singhi, MD - Presenting Faculty, Galveston

Assistant Professor, Department of General Oncology, Division of Cancer Medicine
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology,
The University of Texas MD Anderson Cancer Center, Houston, TX